Clinical trials on PARP inhibitors in urothelial carcinoma (UC) showed limited efficacy and a lack of predictive biomarkers. We propose SLFN5, SLFN11, and OAS1 as UC‐specific response predictors. We suggest Talazoparib as the better PARP inhibitor for UC than Olaparib.
Jutta Schmitz +15 more
wiley +1 more source
Navigating the Challenges: A Commentary on Barriers to Autism Screening in Childcare Centers. [PDF]
Wieckowski AT +6 more
europepmc +1 more source
Cytoplasmic p21 promotes stemness of colon cancer cells via activation of the NFκB pathway
Cytoplasmic p21 promotes colorectal cancer stem cell (CSC) features by destabilizing the NFκB–IκB complex, activating NFκB signaling, and upregulating BCL‐xL and COX2. In contrast to nuclear p21, cytoplasmic p21 enhances spheroid formation and stemness transcription factor CD133.
Arnatchai Maiuthed +10 more
wiley +1 more source
Predicting and identifying correlates of inequalities in breast cancer screening uptake using national level data from India. [PDF]
Tanveer A, Ali RH, Majhi J, Mukherjee M.
europepmc +1 more source
Identification of Sarcopenic Obesity by Fat-to-Muscle Ratio in Older Adults: A Cohort Study. [PDF]
Kakita D +7 more
europepmc +1 more source
Prevention and early intervention screening for inherited ocular diseases in Saudi Arabia: a national perspective. [PDF]
AlEissa MM, Abedalthagafi M, Edward DP.
europepmc +1 more source
Cost-Effectiveness of Home-Based Self-Sampling vs Clinician Sampling for Anal Precancer Screening.
Damgacioglu H +10 more
europepmc +1 more source
Towards accurate malnutrition identification in individuals with Spinal Cord Injury: a qualitative investigation. [PDF]
Keenan SJ +3 more
europepmc +1 more source
Exploring Inclusion in Austria's Breast Cancer Screening:A Dual-Perspective Study of Women with Intellectual Disabilities and Their Caregivers. [PDF]
Wagner T +5 more
europepmc +1 more source

